MedMesh.i
Corpus
Accueil
Racine
Corpus
Exploration
Accueil
Racine
Accueil

Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « MedMesh.i » - entrée « Retinal Diseases »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Retina < Retinal Diseases < Retinal Pigment Epithelium  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000130 (2021) Isabel Fambuena-Muedra ; Marta Jiménez-García ; Sarah Hershko ; Irene Altemir-G Mez ; Ana Tobarra-L PezWhat can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects.
000B74 (2021) Cassandra Doyno ; Diana M. Sobieraj ; William L. BakerToxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
000F54 (2020) Alireza Paniri ; Mohammad Mahdi Hosseini ; Ahmad Rasoulinejad ; Haleh Akhavan-NiakiMolecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations.
001075 (2020) Christopher Stremmel ; Antonia Kellnar ; Steffen Massberg ; Stefan K BHydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia.
001126 (2020) Laurel C. Chandler ; Imran H. Yusuf ; Michelle E. Mcclements ; Alun R. Barnard ; Robert E. Maclaren ; Kanmin XueImmunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy.
001366 (2020) Drew Kuraitis ; Andrea MurinaFacts, not Fear: Safety of Hydroxychloroquine.
001448 (2020) Edgard Torres Dos Reis Neto ; Adriana Maria Kakehasi ; Marcelo De Medeiros Pinheiro ; Gilda Aparecida Ferreira ; Cláudia Diniz Lopes Marques ; Licia Maria Henrique Da Mota ; Eduardo Dos Santos Paiva ; Gecilmara Cristina Salviato Pileggi ; Emília Inoue Sato ; Ana Paula Monteiro Gomides Reis ; Ricardo Machado Xavier ; José Roberto ProvenzaRevisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases.
001591 (2020) S. Defoort-Dhellemmes[Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?]
001619 (2020) Michael F. MarmorCOVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
001757 (2020) Mario R. Romano ; Raffaele Raimondi ; Alessio Montericcio ; Davide AllegriniHydroxychloroquine and ritonavir for COVID-19 infection: a possible synergic toxicity for retinal pigmented epithelium.
001842 (2020) Paisan Ruamviboonsuk ; Timothy Y Y. Lai ; Andrew Chang ; Chi-Chun Lai ; William F. Mieler ; Dennis S C. LamChloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Retinal Diseases" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Retinal Diseases" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Retinal Diseases
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021